Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
Kenemans
Peter
P
D000367:Age Factors; D001943:Breast Neoplasms; D000075202:Contraindications; D020847:Estrogen Receptor Modulators / Q000009:adverse effects; D005260:Female; D006331:Heart Diseases / Q000517:prevention & control; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D009652:Norpregnenes / Q000009:adverse effects; D018579:Patient Selection; D017698:Postmenopause; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced
D020847:Estrogen Receptor Modulators; D009652:Norpregnenes; C027385:tibolone